Ares Serono, a medium-sized Swiss pharmaceutical company, is a world leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech companies in Europe. The case dealt with a number of important strategic and organizational challenges of a new CEO.

Ares Serono, a medium-sized Swiss pharmaceutical company, is a world leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech companies in Europe. The case dealt with a number of important strategic and organizational challenges of a new CEO.
«Hide

from
Michael Y. Yoshino,
Jean-Pierre Jeannet,
Carin-Isabel Knoop
Source: Harvard Business School
43 pages.
Release Date: 08 September 1995. Prod #: 396 035 PDF-ENG
Ares-Serono HBR case solution

[related_post themes="flat"]